Navigation Links
Eye Cell Implants Improve Parkinson's Symptoms
Date:4/28/2008

Small study found measurable gains in those with moderate to severe disease

MONDAY, April 28 (HealthDay News) -- By implanting specialized cells found in the human eye into areas of the brain damaged by Parkinson's disease, researchers were able to reduce symptoms and improve quality of life in people with moderate to severe Parkinson's.

The new treatment, dubbed Spheramine, reduced symptoms experienced when people were off their Parkinson's medications by 44 percent for as long as four years of follow-up. Quality-of-life measurements were up about 23 percent, according to the study, expected to be presented April 29 at the American Association of Neurological Surgeons' annual meeting, in Chicago.

"This is a promising study on a form of therapy that is different from anything out there," said the study's lead author, Dr. Roy Bakay, a professor of neurological surgery and the A. Watson and Sarah Armour Presidential Chair at Rush University Medical Center in Chicago.

"This therapy may be beneficial in itself, or it may be used as additional therapy," added Bakay, who was at Emory University in Atlanta at the time of the study.

Spheramine is made from cells called human retinal pigment epithelial cells (hRPE) that are found naturally in the human eye. By combining these cells with microscopic gelatin beads called microcarrier support matrix (MSM), the Emory researchers were able to produce Spheramine, a targeted therapy for Parkinson's. Spheramine can be implanted in the brain, where the eye cells naturally begin to produce levodopa. The researchers believe the levodopa is then turned into dopamine, a neurotransmitter lacking in people with Parkinson's.

"Spheramine is not stem cells. There's no requirement for immunosuppression, and these cells are easily harvested from eye banks and are readily available," Bakay said.

The new study included six patients with moderate to severe Park
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Physicians Anticipate Changes in Their Usage of Hip Implants
2. UT Southwestern testing new hybrid hearing device combining advantages of hearing aids, implants
3. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
4. Small-Diameter Dental Implants Increasingly Popular In the US
5. Porous structures help boost integration of host tissue with implants, study finds
6. Implants Double Infection Risk After Breast Reconstruction
7. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
8. Freeze-dried tendon implants prove effective in early studies
9. ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants
10. Neural Insights Could Bring Better Cochlear Implants
11. Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Eye Cell Implants Improve Parkinson's Symptoms
(Date:9/2/2015)... NV (PRWEB) , ... September 02, 2015 , ... ... and Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an industry leader ... auction house in the world, selling more than 100,000 pieces of medical equipment ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... people to comfortably hold a tablet while reducing the likelihood of it dropping. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, ... named to the Inc. 5000 List, an independent ranking of the fastest- ... 34 years, and this achievement puts Canopy in rarefied company. Over the years, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... for the telling the truth about medicine and health, truths that other doctors ... blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically directed ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... (FDA) for the treatment of androgenic alopecia in adults, announces Miami-based medical device ... therapy cap, while also demonstrating its safety when used at home to combat ...
Breaking Medicine News(10 mins):Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... ... ... ... ...
... ... ... ... ...
... ... ... , ... , , , ...
... in the March edition of the Journal of ... patient,s outlook as it relates to health behavior and ... discovered that those who exhibited an optimistic disposition experienced ... Previous research into how the body communicates ...
... for advanced endoscopic procedures with a low rate of ... according to a new study in Clinical Gastroenterology ... Gastroenterological Association (AGA) Institute. "This is the ... (AMs) associated with propofol use in endoscopy. We believe ...
... ... objective of the PACT program is to continue to advance cellular ... and biologic systems, and targeted treatments for serious diseases without effective ... research in novel cell therapies, to advance the field of cellular ...
Cached Medicine News:Health News:The First Annual CQ HealthBeat Conference 2Health News:The First Annual CQ HealthBeat Conference 3Health News:The First Annual CQ HealthBeat Conference 4Health News:The First Annual CQ HealthBeat Conference 5Health News:Battling a Biceps Injury 2Health News:Battling a Biceps Injury 3Health News:Battling a Biceps Injury 4Health News:Battling a Biceps Injury 5Health News:Battling a Biceps Injury 6Health News:Battling a Biceps Injury 7Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:Lung cancer research explores the effects of patient attitudes on patient outcomes 2Health News:Adverse events rate is low when propofol is administered by trained professional 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 3
(Date:9/1/2015)... , Sept. 1, 2015  Edwards Lifesciences Corporation ... science of heart valves and hemodynamic monitoring, is scheduled ... Conference at the Hyatt Regency Boston in ... Michael A. Mussallem , Edwards Lifesciences, ... speaker followed by a company discussion with conference attendees ...
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
(Date:9/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that Steven ... and David Haen , Vice President of ... corporate overview at two significant investment conferences in ... industries: the FBR & Co. Second Annual Health ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
... Inc., a medical device development company, today announced the ... (POC) with Auto Mode technology. ... only 4.9 pounds, the LifeChoice POC with Auto Mode ... detect and adjust patient therapy based on oxygen requirements ...
... 2011 OrbusNeich today announced that the company,s Genous ... vessel compared with bare metal stents and drug eluting ... presented by Ladislav Groch, M.D., of the University Hospital ... Research II session at Transcatheter Cardiovascular Therapeutics (TCT) 2011 ...
Cached Medicine Technology:Inova Labs Announces Launch of the LifeChoice Portable Oxygen Concentrator With Auto Mode Technology 2OrbusNeich's Genous™ Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation 2OrbusNeich's Genous™ Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation 3
... One device provides both low ... a single gas source , Reduce ... number of SKUs dedicated to nebulizers ... of double or wye set ups ...
... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
... is improved CNBT technology, which relieves the practitioner ... 15 minutes. HOPE allows you the ability to ... administration couldn't be easier, with a length of ... can turn the HOPE nebulizer into an inexpensive ...
... Thera-Mist® Air Entrainment Nebulizers deliver particulate humidity ... for your chronic secretion patients. For your ... your existing supply of sterile water., ... at FiO2's of 20-50% with a total ...
Medicine Products: